MedPath

EDAP TMS

πŸ‡«πŸ‡·France
Ownership
-
Employees
307
Market Cap
-
Website

Clinical Trials

1

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)β€’ Click on a phase to view related trials

Phase 3
1 (100.0%)

Ultrasound in Treating Patients With Recurrent Stage I or Stage II Prostate Cancer

Phase 3
Terminated
Conditions
Prostate Cancer
First Posted Date
2004-02-25
Last Posted Date
2013-11-06
Lead Sponsor
EDAP Technomed
Registration Number
NCT00005075
Locations
πŸ‡ΊπŸ‡Έ

UCSF Cancer Center and Cancer Research Institute, San Francisco, California, United States

πŸ‡ΊπŸ‡Έ

Baylor College of Medicine, Houston, Texas, United States

News

UCSF Performs World's First OnQ Prostate-Assisted Robotic HIFU Procedure

Cortechs.ai and EDAP TMS SA achieved a milestone with the first-ever OnQ Prostate-assisted Focal One Robotic HIFU procedure performed at UCSF Prostate Center.

EDAP TMS Treats First Patient with HIFU in Pancreatic Cancer Trial

EDAP TMS SA has initiated a Phase I/II trial (PULS) using High Intensity Focused Ultrasound (HIFU) for pancreatic tumor treatment.

EDAP TMS Announces First Patients Treated in Phase I/II Study of Focal One HIFU for Benign Prostatic Hyperplasia

EDAP TMS has initiated a Phase I/II clinical trial evaluating Focal One robotic HIFU for benign prostatic hyperplasia (BPH) treatment.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Β© 2025 MedPath, Inc. All rights reserved.